Viele Betroffene berichten, viel Zeit verloren zu haben, bevor ihnen die klinische Diagnose Blauzapfenmonochromasie gestellt wurde. Der Grund hierfür liegt darin, dass es sich um eine seltene Krankheit handelt und folglich ein auf Erbkrankheiten der Netzhaut spezialisierter Augenarzt zu Rate gezogen werden muss.
Nachstehend sind einige Augenärzte aufgeführt, die bereits Blauzapfenmonochromaten behandelt oder sich in der Forschung mit Blauzapfenmonochromasie und ähnlichen Krankheiten beschäftigt haben.
Einige Augenärzte führen Forschungsarbeiten durch, die von unserer Stiftung finanziert werden. Sie wurden aufgrund ihrer Kompetenz und ihres Interesses für Blauzapfenmonochromasie von uns ausgewählt.
Augenärzte und klinische Zentren, Experte für BCM
Tomas S. Aleman, MD
Scheie Eye Institute
Director, Retinal Function and Structure Laboratories
Director, Retinal Degenerations
Director, Retinal Degeneration and Ophthalmic Genetics Fellowship Program
Irene Heinz-Given and John LaPorte Research Professor
Director Center for Hereditary Retinal Degenerations and Retinal Function Department, Scheie Eye Institute, University of Pennsylvania
Dr. Jacque Duncan, MD
Retinal specialist University of California San Francisco (UCSF) – Retina and Vitreous Clinic
Professor, Ophthalmology School of Medicine, University of California San Francisco
José-Alain Sahel, MD
Distinguished Professor and Chairman
Department of Ophthalmology, University of Pittsburgh School of Medicine
Exceptional Class Professor at Sorbonne Université, Paris
The Eye and Ear Foundation Endowed Chair
The University of Pittsburgh, Department of Ophthalmology
Mark Pennesi, MD, PhD, FARVO
Director, Ophthalmic Genetics
Retina Foundation
Dallas, Texas
Professor of Ophthalmology
Professor of Molecular and Medical Genetics
Paul H. Casey Ophthalmic Genetics DivisionCasey Eye Institute
Oregon Health & Science University
Paul A. Sieving, MD, PhD
Neil and MJ Kelly Presidential Chair
Director, Clinical Service for Inherited Retinal Dystrophies
Research Director, Department of Ophthalmology
Director, Center for Ocular Regenerative Therapy (CORT)
Director, Center for Visual Sciences (CVS)
Professor, Department of Ophthalmology
UC Davis Health, Medical Center
Lawrence J. Ellison Ambulatory Care Center
Ophthalmology Clinic-Eye Center
Edwin M. Stone MD, PhD
Professor of Ophthalmology and Visual Sciences
Director, Carver Nonprofit Genetic Testing Laboratory
Director, Molecular Ophthalmology Laboratory
Director, Carver Family Center for Macular Degeneration
Director, Institute for Vision Research
Seamans-Hauser Chair in Molecular Ophthalmology
University of Iowa Health Care
The University of Iowa Istitute for Vision Research
Marc T. Mathias, MD
Assistant Professor
Vitreoretinal Diseases and Surgery
Department of Ophthalmology
University of Colorado School of Medicine
UCHealth Eye Center
Amy Hutchinson, MD
Professor of Ophthalmology at Emory University School of Medicine
Interim Director of Pediatric Ophthalmology Emory Eye Center
David Birch, MD, PhD
Scientific Director
Director, Rose-Silverthorne Retinal Degenerations Laboratory
Retina Foundation of the Southwest
Robert Hufnagel, MD, PhD
Director, Medical Genetics and Ophthalmic Unit
Co-Director, Ophthalmic Genomics Laboratory
NIH, National Eye Institute
Paul Yang, MD, PhD
Chief, Paul H. Casey Ophthalmic Genetics Division
Associate Professor of Ophthalmology, School of Medicine
OHSU, Casey Eye Institute
Anne B. Fulton, MD
Professor of Ophthalmology
Harward Medical School, Department of Ophthalmology
Boston Children’s Hospital
Byron M. Lam, MD
Professor of Ophthalmology
Dr. Mark J. Daily Endowed Chair in Ophthalmology
Bascom Palmer Eye Institute
University of Miami Health System
Alessandro Iannaccone, MD, MS, FARVO
Global Medical Lead, Cell and Gene Therapy, Ophthalmology
Astellas Pharma US und
The University of North Carolina (UNC) at Chapel Hill, School of Medicine, Ophthalmology